文献速递疼痛医学术前评估与围术期医学

门诊慢性疼痛药物治疗的当代医疗法律分析

A Contemporary Medicolegal Analysis of Outpatient Medication Management in Chronic Pain.
PubMed 文献 · Anesth Analg · 2017-01-01

本研究基于CRICO理赔数据库2009至2013年的37例非介入性门诊慢性疼痛管理闭环索赔,分析患者合并症、异常药物行为及处方者实践与患者伤害和医疗事故索赔的关系。结果显示27%案件发生赔付,中位赔付72,500美元,约49%涉及患者死亡,长效阿片类药物及心肺系统疾病与死亡更相关。

要点

  • 长效阿片类药物和心肺合并症与死亡结局更相关。
  • 患者行为贡献超过半数索赔,临床判断缺陷约占40%。
  • 谨慎选择慢性阿片治疗患者并记录依从性可降低风险。

核心结论

  • 门诊疼痛医学药物治疗相关索赔是多因素的,源于医生临床判断缺陷、患者不合作和临床记录不佳。
  • 通过谨慎选择慢性阿片治疗患者并记录依从性和治疗改善,可减少法律风险和患者伤害。

研究设计与样本

  • 研究为对闭环医疗事故索赔的回顾性分析,数据来自CRICO Strategies比较基准系统,覆盖超过350,000例索赔。

主要发现

  • 患者平均年龄43.5岁,男性占59.5%。
  • 27%案件发生赔付,中位赔付72,500美元,范围7,500至687,500美元。
  • 约49%案件涉及患者死亡。
  • 大多数案件与脊柱退行性关节病和腰椎手术失败综合征相关,无恶性肿瘤疼痛治疗病例。
  • 长效阿片类药物使用及影响心肺系统的疾病与死亡比其他结局更密切相关。

关键数值与推荐

  • 非疼痛合并症包括肥胖、阻塞性睡眠呼吸暂停、慢性阻塞性肺疾病、高血压和冠状动脉疾病。
  • CRICO分析提示患者行为贡献超过半数索赔,临床判断缺陷贡献约40%的索赔。

临床怎么用

  • 应仔细选择慢性阿片治疗患者,并记录依从性和治疗计划改善情况。
  • 需特别警惕阻塞性睡眠呼吸暂停等合并症及长效阿片类药物的使用风险。
  • 持续医生教育关于最安全和有效的药物管理方法可改善法律安全和患者安全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioids are frequently used in chronic pain management but are associated with significant morbidity and mortality in some patient populations. An important avenue for identifying complications-including serious or rare complications-is the study of closed malpractice claims. The present study is intended to complement the existing closed claims literature by drawing on claims from a more recent timeframe through a partnership with a large malpractice carrier, the Controlled Risk Insurance Company (CRICO). The goal of this study was to identify patient medical comorbidities and aberrant drug behaviors, as well as prescriber practices associated with patient injury and malpractice claims. Another objective was to identify claims most likely to result in payments and use this information to propose a strategy for reducing medicolegal risk. METHODS: The CRICO Strategies Comparative Benchmarking System is a database of claims drawing from >350,000 malpractice claims from Harvard-affiliated institutions and >400 other academic and community institutions across the United States. This database was queried for closed claims from January 1, 2009, to December 31, 2013, and identified 37 cases concerning noninterventional, outpatient chronic pain management. Each file consisted of a narrative summary, including expert witness testimony, as well as coded fields for patient demographics, medical comorbidities, the alleged damaging event, the alleged injurious outcome, the total financial amount incurred, and more. We performed an analysis using these claim files. RESULTS: The mean patient age was 43.5 years, with men representing 59.5% of cases. Payments were made in 27% of cases, with a median payment of $72,500 and a range of $7500-$687,500. The majority of cases related to degenerative joint disease of the spine and failed back surgery syndrome; no patients in this series received treatment of malignant pain. Approximately half (49%) of cases involved a patient death. The use of long-acting opioids and medical conditions affecting the cardiac and pulmonary systems were more closely associated with death than with other outcomes. The nonpain medical conditions present in this analysis included obesity, obstructive sleep apnea, chronic obstructive pulmonary disease, hypertension, and coronary artery disease. Other claims ranged from alleged addiction to opioids from improper prescribing to alleged abandonment with withdrawal of care. The CRICO analysis suggested that patient behavior contributed to over half of these claims, whereas deficits in clinical judgment contributed to approximately 40% of the claims filed. CONCLUSIONS: Claims related to outpatient medication management in pain medicine are multifactorial, stemming from deficits in clinical judgment by physicians, noncooperation in care by patients, and poor clinical documentation. Minimization of both legal risk and patient harm can be achieved by carefully selecting patients for chronic opioid therapy and documenting compliance and improvement with the treatment plan. Medical comorbidities such as obstructive sleep apnea and the use of long-acting opioids may be particularly dangerous. Continuing physician education on the safest and most effective approaches to manage these medications in everyday practice will lead to both improved legal security and patient safety.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Abrecht CR, Brovman EY, Greenberg P, et al. A Contemporary Medicolegal Analysis of Outpatient Medication Management in Chronic Pain. Anesth Analg. 2017. PMID: 29049120. doi:10.1213/ANE.0000000000002499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。